For research use only. Not for therapeutic Use.
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1[1].
Metelimumab (0.5 pg/mL-50 μg/mL) inhibits TGFβ1-stimulated IL-11 production in an A549 cell[1].
Catalog Number | I042411 |
CAS Number | 272780-74-2 |
Purity | ≥95% |
Reference | [1]. Lord DM, et, al. Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody. MAbs. 2018 Apr;10(3):444-452. |